Haleon plc (HLN) NYSE

Currency In USD

AD

Haleon plc

Address

Building 5

Weybridge, KT13 0NY

United Kingdom of Great Britain and Northern Ireland (the)

Phone

44 1932 822000

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

24561

First IPO Date

July 25, 2022

Key Executives

NameTitlePayYear Born
Brian James McNamaraChief Executive Officer & Executive Director3.78M1966
Dawn Amanda AllenChief Financial Officer & Director2.04M1968
Adrian Charles MorrisGeneral Counsel01967
Bjorn TimelinHead of Strategy0N/A
Filippo LanziPresident of EMEA & LatAm0N/A
Keith ChoyPresident of Asia Pacific01969
Claire DicksonChief Digital & Technology Officer0N/A
Joanne RussellHead of Investor Relations0N/A
Line De DeckerChief Human Resources Officer01974
Namrata PatelChief Supply Chain Officer01966
Tamara RogersChief Marketing Officer01968
AD

Description

Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods. The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region. Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within its collection include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially known as DRVW 2022 plc before officially changing its name to Haleon plc in February 2022. It is headquartered in Brentford, United Kingdom.

AD